US 12,237,064 B2
System, method and article for controlling the dispensing of insulin
Robert C. Kircher, Jr., Seattle, WA (US); Richard S. Mauseth, Woodinville, WA (US); Jason N. Bishop, Bellevue, WA (US); Donald P. Matheson, Redmond, WA (US); Suray Bhatia, Seattle, WA (US); and Jeff A. Bilmes, Seattle, WA (US)
Assigned to Dexcom, Inc., San Diego, CA (US)
Filed by Dexcom, Inc., San Diego, CA (US)
Filed on May 25, 2022, as Appl. No. 17/824,042.
Application 17/824,042 is a continuation of application No. 16/857,030, filed on Apr. 23, 2020, granted, now 11,373,748.
Application 16/857,030 is a continuation of application No. 16/118,555, filed on Aug. 31, 2018, granted, now 10,668,214, issued on Jun. 2, 2020.
Application 16/118,555 is a continuation of application No. 15/606,839, filed on May 26, 2017, granted, now 10,080,842, issued on Sep. 25, 2018.
Application 15/606,839 is a continuation of application No. 14/710,851, filed on May 13, 2015, granted, now 9,694,133, issued on Jul. 4, 2017.
Application 14/710,851 is a continuation of application No. 14/014,711, filed on Aug. 30, 2013, granted, now 9,056,168, issued on Jun. 16, 2015.
Application 14/014,711 is a continuation of application No. 12/305,582, granted, now 8,548,544, issued on Oct. 1, 2013, previously published as PCT/US2007/014477, filed on Jun. 19, 2007.
Claims priority of provisional application 60/815,235, filed on Jun. 19, 2006.
Claims priority of provisional application 60/859,625, filed on Nov. 17, 2006.
Claims priority of provisional application 60/904,495, filed on Mar. 1, 2007.
Prior Publication US 2022/0375566 A1, Nov. 24, 2022
Int. Cl. G16H 20/17 (2018.01); A61B 5/145 (2006.01); A61M 5/172 (2006.01); G06N 5/048 (2023.01); G16H 20/10 (2018.01); G16H 20/13 (2018.01); G16H 50/50 (2018.01)
CPC G16H 20/17 (2018.01) [A61B 5/14532 (2013.01); A61M 5/1723 (2013.01); G06N 5/048 (2013.01); G16H 20/10 (2018.01); G16H 20/13 (2018.01); G16H 50/50 (2018.01); A61M 2230/005 (2013.01); A61M 2230/201 (2013.01)] 40 Claims
OG exemplary drawing
 
1. A blood glucose control system, comprising:
a data input subsystem configured to receive and store blood glucose-related data;
an output subsystem configured to generate a control signal to control dispensing of insulin based on the received blood glucose-related data and fuzzy-logic control parameters;
a parameter adjuster configured to adjust the fuzzy-logic control parameters based on the received and the stored blood-glucose related data; and
a pen-dispensing device coupled to the output subsystem.